Determinants of and Interventions for Proton Pump Inhibitor Prescription Behavior: A Systematic Scoping Review

Overview

Journal BMC Prim Care

Specialties Health Services
Public Health

Date 2024 Jun 11

PMID 38862886

Authors

L C van Gestel

M A Adriaanse

S L Kanis

S M Mensink-Bout

J W Schoones

M E Numans

J C Kiefte-de Jong

G van den Brink

Affiliations

Soon will be listed here.

Abstract

Background: Proton Pump Inhibitors (PPI) are frequently prescribed. Long-term use is associated with side-effects and patients often lack a valid indication. Inappropriate PPI prescribing thus needs to be addressed. This review aims to scope 1) what determinants are studied as reasons for PPI prescribing, 2) what strategies are used for changing PPI (de)prescribing, and 3) whether important determinants are addressed in these interventions.

Methods: We searched eight databases for papers on determinants of physician PPI prescribing. Studies were included if they were conducted in a Western country and focused on oral PPIs for an adult population. By following the Behaviour Change Wheel, we extracted information regarding PPI prescribing behavior, behavioral determinants and intervention strategies.

Findings: We included 74 papers. Most focused on the determinants knowledge and beliefs about consequences. The latter was consistently related to PPI prescribing. Results for knowledge were mixed. Most interventions used education or enablement (e.g., algorithms, quality check improvements, involvement of pharmacists) as strategies. Enablement consistently improved PPI prescribing, while results for education were mixed.

Interpretation: There is an overemphasis on reflective processes in studies on PPI prescribing. Future research should comprehensively identify behavioral determinants, focusing on reflective and impulsive processes, such that interventions can address the most important determinants.

References

Thompson W, Hogel M, Li Y, Thavorn K, ODonnell D, McCarthy L . Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care. J Am Med Dir Assoc. 2016; 17(7):673.e1-4. DOI: 10.1016/j.jamda.2016.04.020. View

Calvo L, Garcia Camara P, Llorente Barrio M, Sierra Gabarda O, Monzon Baez R, Arbones Mainar J . Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project. Eur J Clin Pharmacol. 2021; 77(12):1927-1933. DOI: 10.1007/s00228-021-03186-x. View

Lin D, Eke C, Cai C, Thrift A, Shukla R . Decreasing Overall and Inappropriate Proton Pump Inhibitor Use: Perspective From a Large Safety-Net Healthcare System. Clin Gastroenterol Hepatol. 2019; 18(4):763-766.e2. DOI: 10.1016/j.cgh.2019.12.015. View

Hurenkamp G, Grundmeijer H, Bindels P, Tytgat G, van der Hulst R . [Chronic use of stomach acid inhibitor medication in family practice in the region of Amsterdam]. Ned Tijdschr Geneeskd. 1999; 143(8):410-3. View

Atkins L, Francis J, Islam R, OConnor D, Patey A, Ivers N . A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017; 12(1):77. PMC: 5480145. DOI: 10.1186/s13012-017-0605-9. View

Grimshaw J, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L . Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001; 39(8 Suppl 2):II2-45. View

Ghosh G, Schnoll-Sussman F, Mathews S, Katz P . Reported proton pump inhibitor side effects: what are physician and patient perspectives and behaviour patterns?. Aliment Pharmacol Ther. 2019; 51(1):121-128. DOI: 10.1111/apt.15522. View

Buckley M, Park A, Anderson C, Barletta J, Bikin D, Gerkin R . Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients. Am J Med. 2015; 128(8):905-13. DOI: 10.1016/j.amjmed.2015.02.014. View

Potthoff S, Rasul O, Sniehotta F, Marques M, Beyer F, Thomson R . The relationship between habit and healthcare professional behaviour in clinical practice: a systematic review and meta-analysis. Health Psychol Rev. 2019; 13(1):73-90. DOI: 10.1080/17437199.2018.1547119. View

10.

Wilsdon T, Hendrix I, Thynne T, Mangoni A . Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults. Drugs Aging. 2017; 34(4):265-287. DOI: 10.1007/s40266-017-0442-1. View

11.

Shanika L, Reynolds A, Pattison S, Braund R . Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol. 2023; 79(9):1159-1172. PMC: 10427555. DOI: 10.1007/s00228-023-03534-z. View

12.

Koggel L, Lantinga M, Buchner F, Drenth J, Frankema J, Heeregrave E . Predictors for inappropriate proton pump inhibitor use: observational study in primary care. Br J Gen Pract. 2022; 72(725):e899-e906. PMC: 9512410. DOI: 10.3399/BJGP.2022.0178. View

13.

Haastrup P, Thompson W, Sondergaard J, Jarbol D . Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic Clin Pharmacol Toxicol. 2018; 123(2):114-121. DOI: 10.1111/bcpt.13023. View

14.

Batuwitage B, Kingham J, Morgan N, Bartlett R . Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J. 2007; 83(975):66-8. PMC: 2599965. DOI: 10.1136/pgmj.2006.051151. View

15.

Clyne B, Smith S, Hughes C, Boland F, Cooper J, Fahey T . Sustained effectiveness of a multifaceted intervention to reduce potentially inappropriate prescribing in older patients in primary care (OPTI-SCRIPT study). Implement Sci. 2016; 11(1):79. PMC: 4890249. DOI: 10.1186/s13012-016-0442-2. View

16.

Raghunath A, Hungin A, Cornford C, Featherstone V . Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners. Digestion. 2005; 72(4):212-8. DOI: 10.1159/000089727. View

17.

Bundeff A, Zaiken K . Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice. J Manag Care Pharm. 2013; 19(4):325-33. PMC: 10438075. DOI: 10.18553/jmcp.2013.19.4.325. View

18.

Gillespie R, Mullan J, Harrison L . Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia. Health Soc Care Community. 2022; 30(6):e6206-e6216. PMC: 10087828. DOI: 10.1111/hsc.14058. View

19.

Vassiliou V, Silva A, Kavvoura F, Schofield R, Rowlands D . Reducing co-administration of clopidogrel and proton pump inhibitors in acute coronary syndromes. J R Coll Physicians Edinb. 2012; 42(1):21-3. DOI: 10.4997/JRCPE.2012.105. View

20.

Leiman D, Ravi K, Freedberg D, Gyawali C . Proton Pump Inhibitor Prescribing and Monitoring Patterns Among Gastroenterology Practitioners. J Clin Gastroenterol. 2021; 56(7):571-575. DOI: 10.1097/MCG.0000000000001623. View